Search results
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks· 6 days agoAn FDA advisory committee meeting to discuss Eli Lilly’s (LLY...s (MRK Quick QuoteMRK - Free Report) phase III study evaluating a Keytruda-based regimen for an endometrial ...
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 7 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Top Stock Reports for Broadcom, Merck & Airbnb
Zacks via Yahoo Finance· 18 hours agoToday's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck & Co., Inc. (MRK) and Airbnb, Inc. (ABNB).
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks· 3 days agoFree Report) recently announced that a late-stage study, seeking to expand the label of its cancer combination drug, Opdivo (nivolumab) and Yervoy (ipilimumab ...
ImmunityBio Advances On the Anktiva Front
Los Angeles Business Journal· 3 days agoImmunityBio Inc., the Culver City-based immunotherapy company founded by billionaire Patrick Soon-Shiong that last month won Food and Drug Administration approval for its ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 6 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Merck's endometrial cancer therapy fails trial
Reuters· 7 days ago, opens new tab said on Thursday its therapy being tested in certain patients with a type of cancer in the uterus lining failed a late-stage trial. The...
2 No-Brainer Dividend Stocks to Buy in May | The Motley Fool
The Motley Fool· 7 days agoAfter all, dividend payments have accounted for approximately 85% of the S&P 500's total returns since 1960, per a report by Hartford Funds. Which dividend stocks are worth buying in the current ...
Blockbuster Drug Patent Thickets Signal 'Strategic Behavior'
MedPage Today· 3 days agoAn analysis of patent applications for 10 top-selling prescription drugs found that nearly...
